Ardigo Marco

Dr. Ardigo Marco

Department of Clinical Dermatology, San Gallicano Dermatological Institute, Via Chianesi 53, 00144 Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2001 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
BPBelinda Palermo
Belinda Palermo
RCRita Campanelli
Rita Campanelli
SGSilvia Garbelli
Silvia Garbelli
SMStefania Mantovani
Stefania Mantovani
ELErica Lantelme
Erica Lantelme
Claudia GiachinoClaudia Giachino
Claudia Giachino

30 September 2004 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
RFRegina Fink‐Puches
Regina Fink‐Puches
ACAndreas Chott
Andreas Chott
Ardigo MarcoArdigo Marco
Ardigo Marco
ISIngrid Simonitsch
Ingrid Simonitsch
GFGerardo Ferrara
Gerardo Ferrara
LCLorenzo Cerroni
Lorenzo Cerroni

22 December 2010 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
Giuseppe ArgenzianoGiuseppe Argenziano
Giuseppe Argenziano
CCC. Catricalà
C. Catricalà
Ardigo MarcoArdigo Marco
Ardigo Marco
PBP. Buccini
P. Buccini
PSPaola De Simone
Paola De Simone
IZI. Zalaudek
I. Zalaudek

1 October 2002 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
ASAlessandra Scarabello
Alessandra Scarabello
BLBernd Leinweber
Bernd Leinweber
Ardigo MarcoArdigo Marco
Ardigo Marco
ARArno Rütten
Arno Rütten
AFAlfred C. Feller
Alfred C. Feller
LCLorenzo Cerroni
Lorenzo Cerroni
The presence of a granulomatous reaction in lesions of cutaneous lymphomas has been described in the past in several cases. Especially in mycosis fungoides, a “granulomatous” variant of the disease has been well characterized. We studied the clinicopathologic features of cutaneous lymphomas with prominent granulomatous reaction, including both cutaneous T-cell lymphomas and B-cell lymphomas (primary cutaneous lymphoma 22, secondary cutaneous lymphoma one). Biopsies of 23 patients with histopathologic features of cutaneous T-cell lymphoma or cutaneous B-cell lymphoma with prominent granulomatous reaction were included in this study. A prominent granulomatous reaction was defined as the presence of a granulomatous component exceeding 25% of the dermal infiltrate. There were 14 cases of mycosis fungoides, two of subcutaneous panniculitis-like T-cell lymphoma, four of small/medium pleomorphic T-cell lymphoma, one of follicle center cell lymphoma, one of large B-cell lymphoma, and one of secondary cutaneous peripheral T-cell lymphoma. Altogether, a prominent granulomatous reaction could be observed in 1.8% of all patients with cutaneous lymphoma (primary or secondary) registered in the files of the Department of Dermatology of the University of Graz (Graz, Austria), demonstrating that there is a distinct, albeit small, proportion of cases revealing this peculiar reaction pattern. In seven cases a misdiagnosis of granulomatous dermatitis preceded the correct diagnosis for a period of 1–216 months, suggesting that sequential biopsies and complete phenotypic and molecular genetic analyses should be carried out in cases of “unusual” granulomatous dermatitis.

1 June 2009 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
Ardigo MarcoArdigo Marco
Ardigo Marco
CCC Cota
C Cota
Enzo BerardescaEnzo Berardesca
Enzo Berardesca
SGS González
S González

1 March 2001 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
CVC. Vassallo
C. Vassallo
FPFabrizio Passamonti
Fabrizio Passamonti
SMS. Merante
S. Merante
Ardigo MarcoArdigo Marco
Ardigo Marco
GNG. Nolli
G. Nolli
GBG. Borroni
G. Borroni